280 related articles for article (PubMed ID: 15524016)
1. [Pharmacoeconomics of asthma].
Jahnz-Rózyk K; Targowski T
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():48-9. PubMed ID: 15524016
[TBL] [Abstract][Full Text] [Related]
2. [Introduction to asthma and chronic obstructive pulmonary disease pharmacoeconomics].
Jahnz-Rózyk K
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():5-6, 8. PubMed ID: 15524004
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacoeconomics of chronic obstructive pulmonary disease].
Jahnz-Rózyk K
Pneumonol Alergol Pol; 2009; 77(3):302-4. PubMed ID: 19591104
[No Abstract] [Full Text] [Related]
4. [The pharmacoeconomics of asthma].
Plaza Moral V
Arch Bronconeumol; 1999 May; 35 Suppl 3():22-6. PubMed ID: 10410220
[No Abstract] [Full Text] [Related]
5. [Pharmacoeconomic aspects of bronchial asthma].
Prosekova EV; Gel'tser BI; Shestovskaia TN
Ter Arkh; 2000; 72(3):55-8. PubMed ID: 10776656
[No Abstract] [Full Text] [Related]
6. [Quality assurance of drug therapy for patients with asthma. Health economic analysis].
Søndergaard B; Thorleifsson S; Herborg H; Frøkjaer B; Hepler CD; Ersbøll BK
Ugeskr Laeger; 2000 Jan; 162(4):480-6. PubMed ID: 10697444
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the cost-effectiveness of omalizumab.
Campbell JD; Spackman DE; Sullivan SD
Allergy; 2007 Dec; 62(12):1469. PubMed ID: 17983382
[No Abstract] [Full Text] [Related]
8. Asthma medication.
Rogol PR
Conn Med; 2008 Aug; 72(7):441. PubMed ID: 18763675
[No Abstract] [Full Text] [Related]
9. Response to Campbell, Spackman, Sullivan letter to Allergy.
Brown R; Turk F; Dale P; Bousquet J
Allergy; 2008 Jun; 63(6):783. PubMed ID: 18445194
[No Abstract] [Full Text] [Related]
10. [Analyzing the economy, something is changing concerning asthma].
Serra Batlles J
Arch Bronconeumol; 2009 Oct; 45(10):475-7. PubMed ID: 19758739
[No Abstract] [Full Text] [Related]
11. [Cost-of-illness of asthma in Denmark in the year 2000].
Mossing R; Nielsen GD
Ugeskr Laeger; 2003 Jun; 165(26):2646-9. PubMed ID: 12886546
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.
Sullivan SD; Turk F
Allergy; 2008 Jun; 63(6):670-84. PubMed ID: 18445184
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of current and optimal treatment for adult asthma.
Simonella L; Marks G; Sanderson K; Andrews G
Intern Med J; 2006 Apr; 36(4):244-50. PubMed ID: 16640742
[TBL] [Abstract][Full Text] [Related]
14. Barriers to effective pediatric asthma care.
Swartz MK; Banasiak NC; Meadows-Oliver M
J Pediatr Health Care; 2005; 19(2):71-9. PubMed ID: 15750551
[TBL] [Abstract][Full Text] [Related]
15. The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care.
Arnlind MH; Nokela M; Rehnberg C; Jonsson EW
J Asthma; 2006 Oct; 43(8):585-91. PubMed ID: 17050222
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab for severe allergic asthma: dollars and sense.
Krishnan JA; Gould M
J Allergy Clin Immunol; 2007 Nov; 120(5):1015-7. PubMed ID: 17983869
[No Abstract] [Full Text] [Related]
17. A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II).
Sullivan SD; Lee TA; Blough DK; Finkelstein JA; Lozano P; Inui TS; Fuhlbrigge AL; Carey VJ; Wagner E; Weiss KB
Arch Pediatr Adolesc Med; 2005 May; 159(5):428-34. PubMed ID: 15867115
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of asthma controller therapies: influence of disease severity and other variables.
Navarro RP; Parasuraman B
Manag Care Interface; 2005 Jun; 18(6):31-40. PubMed ID: 16018297
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma.
Brown R; Turk F; Dale P; Bousquet J
Allergy; 2007 Feb; 62(2):149-53. PubMed ID: 17298423
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacotherapeutical management of bronchial asthma].
Leont'ev SL; Mikhaĭlov VG; Nevzorova VP; Sadovnikova RV; Shabashov AF; Lugovkina TK; Leshchenko IV; Bel'tiukov EK; Lebedeva MK
Klin Med (Mosk); 1998; 76(10):39-41. PubMed ID: 9865016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
